Product Information

CARBIDOPA-LEVODOPA 25-100 TAB is a generic product labeled by American Health Packaging, priced at $0.0736 per EA under NDC 60687066101. Its NADAC has been published 228 times since Jul 6, 2022.

FDA first approved this application on Sep 3, 1993. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CARBIDOPA-LEVODOPA 25-100 TAB

Carbidopa and Levodopa
$0.0736per EA

Strength

25; 100 mg/1; mg/1

NDC

60687066101

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

CARBIDOPA; LEVODOPA

Approval Type

Generic (ANDA)

FDA Application

ANDA074260

FDA Approved

9/3/1993

TE Code

AB

On Market Since

5/27/2022

Pharmacological Classes

Amino Acids
Aromatic
Aromatic Amino Acid

Price Statistics

The NADAC for CARBIDOPA-LEVODOPA 25-100 TAB has been published 228 times since Jul 6, 2022, and over the history we have for it it has declined 31.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0736 per EA
All-time high$0.1196 (Sep 14, 2022)
All-time low$0.0617 (Nov 20, 2024)
52-week high$0.0793
52-week low$0.0719
Median price$0.0899
Average price$0.0902
Largest weekly change-30.7% (Nov 20, 2024)
Weeks tracked228
Tracking sinceJul 6, 2022

Price History

1W

0.0%

1M

-3.0%

3M

-2.5%

6M

+1.7%

1Y

-7.8%

3Y

-21.8%

5Y

N/A

All

-31.6%

Generic Alternatives

The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CARBIDOPA-LEVODOPA 25-100 TAB?

The current National Average Drug Acquisition Cost (NADAC) for CARBIDOPA-LEVODOPA 25-100 TAB, manufactured by American Health Packaging, is $0.0736 per EA (NDC 60687066101), effective Nov 11, 2026.

How has the price of CARBIDOPA-LEVODOPA 25-100 TAB changed over time?

Over the history we have for it, the NADAC for CARBIDOPA-LEVODOPA 25-100 TAB has declined 31.6%. It has been tracked across 228 weekly CMS publications since Jul 6, 2022.

What are the highest and lowest recorded NADAC prices for CARBIDOPA-LEVODOPA 25-100 TAB?

Since Jul 6, 2022, the NADAC for CARBIDOPA-LEVODOPA 25-100 TAB has ranged from a low of $0.0617 (Nov 20, 2024) to a high of $0.1196 (Sep 14, 2022), with a median of $0.0899 per EA.

Are there cheaper alternatives to CARBIDOPA-LEVODOPA 25-100 TAB?

9 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CARBIDOPA-LEVODOPA 25-100 TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures CARBIDOPA-LEVODOPA 25-100 TAB?

CARBIDOPA-LEVODOPA 25-100 TAB (NDC 60687066101) is labeled by American Health Packaging, and CMS classifies it as a generic product.